$15.44
4.40% yesterday
NYSE, Nov 12, 10:00 pm CET
ISIN
NL0000200384
Symbol
CLB

Core Laboratories NV Stock price

$15.44
+4.49 41.00% 1M
+3.38 28.03% 6M
-1.87 10.80% YTD
-5.51 26.30% 1Y
-7.04 31.32% 3Y
-2.14 12.17% 5Y
-100.56 86.69% 10Y
-1.35 8.05% 20Y
NYSE, Closing price Wed, Nov 12 2025
-0.71 4.40%
ISIN
NL0000200384
Symbol
CLB
Sector

Key metrics

Basic
Market capitalization
$752.0m
Enterprise Value
$840.5m
Net debt
$88.5m
Cash
$25.6m
Shares outstanding
46.1m
Valuation (TTM | estimate)
P/E
23.8 | 22.2
P/S
1.5 | 1.4
EV/Sales
1.6 | 1.6
EV/FCF
24.4
P/B
2.8
Dividends
DPS
$0.04
Yield 1Y | 5Y
0.3% | 0.2%
Growth 1Y | 5Y
0.0% | -32.2%
Payout 1Y | 3Y
6.1% | 6.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$517.5m | $518.7m
EBITDA
$72.4m | $72.0m
EBIT
$57.8m | $55.7m
Net Income
$32.1m | $33.5m
Free Cash Flow
$34.4m
Growth (TTM | estimate)
Revenue
-1.0% | -1.0%
EBITDA
-6.2% | -5.0%
EBIT
-6.8% | -8.4%
Net Income
22.6% | 6.8%
Free Cash Flow
-21.4%
Margin (TTM | estimate)
Gross
20.0%
EBITDA
14.0% | 13.9%
EBIT
11.2%
Net
6.2% | 6.5%
Free Cash Flow
6.6%
Financial Health
Equity Ratio
42.7%
Return on Equity
12.5%
ROCE
11.7%
ROIC
8.4%
Debt/Equity
0.4
More
EPS
$0.7
FCF per Share
$0.7
Short interest
38.3%
Employees
3k
Rev per Employee
$160.0k
Show more

Is Core Laboratories NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

Core Laboratories NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Core Laboratories NV forecast:

1x Buy
10%
3x Hold
30%
6x Sell
60%

Analyst Opinions

10 Analysts have issued a Core Laboratories NV forecast:

Buy
10%
Hold
30%
Sell
60%

Financial data from Core Laboratories NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
518 518
1% 1%
100%
- Direct Costs 414 414
0% 0%
80%
103 103
4% 4%
20%
- Selling and Administrative Expenses 44 44
11% 11%
8%
- Research and Development Expense - -
-
-
72 72
6% 6%
14%
- Depreciation and Amortization 15 15
3% 3%
3%
EBIT (Operating Income) EBIT 58 58
7% 7%
11%
Net Profit 32 32
23% 23%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Core Laboratories NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Core Laboratories NV Stock News

Positive
Seeking Alpha
20 days ago
Supplier of residential thermal, comfort and security solutions, Resideo Technologies, Inc. (REZI) was the top contributor in the quarter. Shares of gold mining company, Barrick Mining Corporation (B) also jumped in the quarter on strong financial results buoyed by rising gold prices. We added Arthur J. Gallagher & Co. (AJG), the world's largest insurance broker focused on middle-market clients.
Neutral
Seeking Alpha
21 days ago
Core Laboratories Inc. (NYSE:CLB ) Q3 2025 Earnings Call October 23, 2025 8:30 AM EDT Company Participants Lawrence Bruno - Chairman of the Board, CEO, President & COO Gwendolyn Schreffler - Senior Vice President of Corporate Development & Investor Relations Chris Hill - Senior VP & CFO Conference Call Participants John Daniel - Daniel Energy Partners, LLC Presentation Operator Good day, and we...
Neutral
PRNewsWire
21 days ago
HOUSTON, Oct. 22, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2025 revenue of $134,500,000. Core's operating income was $20,900,000, with earnings per diluted share ("EPS") of $0.30, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, w...
More Core Laboratories NV News

Company Profile

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Lawrence Bruno
Employees 3,300
Founded 2012
Website www.corelab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today